Citrobacter which was considered to be pathogenic bacteria (figure1B). The amounts 1 1 0 of species each recipient gained from their donor after FMT were showed in figure 1 1 1 S1. 1 1 2
Bacterial engraftment evaluation at the species level 1 1 3
To investigate to what extent recipients' microbiome could be altered, we evaluated 1 1 4 both its degree and direction of change after FMT. For clear clarification of the origins 1 1 5 of post-FMT patients' microbiome, we divided their microbiome composition into 1 1 6 four parts: donor-specific species, recipient-specific species, donor-and recipient-1 1 7 specific species (common species), and newly species. Results showed that microbial 1 1 8 communities underwent large compositional changes after FMT and changes 1 1 9 maintained throughout the follow-up time visits (figure 1B). 1 2 0
On average, 29.4% of the mOTUs came from the donor (n = 11, SD = 14.4%) in CD 1 2 1 patients, while 28.2% of the mOTUs came from the donor (n = 4, SD= 20%) in UC 1 2 2 patients. Species gained from donor in both types of IBD were not significantly 1 2 3 differed (p = 0.89). Our results were very similar to previous study (35% of the 1 2 4 mg-OTUs in the donor (n = 436, SD = 27%) (9). As for EEN treatment, on average, 1 2 5 48.6% of the mOTUs were newly gained (n = 14, SD = 24.1%) which instigated more 1 2 6 variation at the species level compared with autologous FMT individuals from Simone 1 2 7 S. Li paper (9). 1 2 8
Aiming at monitoring the direction of changes of IBD patients after FMT, we 1 2 9 measured the distance across donor-recipient pairs using Euclidean distance (Figure 1 3 0 2A). Results varied between different donor-recipient pairs. With only 4 patients have 1 3 1 2 follow-up time points, we found that CD-9 and UC-2 tended to be closer to their 1 3 2 donors and further from their pre-FMT status.CD-2 showed a slightly tendency to be 1 3 3 back to its initial status, yet the disturbance can be ignored (from 10.628 to 10.57). 1 3 4
Surprisingly, CD-1 showed an increased distance both from their donor and pre-FMT 1 3 5 status. Though CD-1,2 and UC-2 shared the same donor, the direction of their gut 1 3 6 flora change after FMT varied. Besides, we explored the consistency of the abundance 1 3 7 of mOTUs in the patients before and after FMT ( Figure 2B ). As expectedly, mOTUs 1 3 8 in post-FMT patients had high correlation with those in the pre-FMT patient (median 1 3 9 cosine similarity of UC patient mOTUs = 0.93, that of CD patients = 0.95). More 1 4 0 importantly, results showed that the mOTUs in the post-FMT patient were perfectly 1 4 1 correlated those in the donor (median cosine similarity of UC patient mOTUs =0.95, 1 4 2 that of CD patients = 0.91). Therefore, bacterial species in the post-FMT patient are 1 4 3 shaped both by the host and donor. To compare the extent of strain-level changes among the study groups, we monitored 1 4 6 those identified SNVs in baseline samples over all available time points. A higher 1 4 7 level of single-site allelic variation in UC FMT recipients was observed compared 1 4 8 with autologous FMT recipients (P= 0.0056) from a previous paper (9), CD FMT 1 4 9 recipients(P=0.070) and EEN treatment(P=0.059). Higher level of SNV was also 1 5 0 observed in CD FMT recipients and EEN treatment than that in the autologous FMT To investigate whether the increased variation was due to the transfer and 1 5 5 establishment of donor microbiota or not, we followed methods defined in a 1 5 6 previously published paper (9). Across recipients, we observed the transfer of donor 1 5 7 strains (figure 4). Donor-specific SNVs were most highly retained 3 days after FMT 1 5 8 (UC: 62.8 ±25.3% of determinant positions across recipients, CD: 11 .4 ±10.3%) and 1 5 9
were still presented 1 months later (UC: 46.9%, CD: 19.99 ±10.1%). This contrasted 1 6 0 with much lower rates of variation observed at equivalent time points in autologous 1 6 1 FMT recipients (9.5 ± 1.8%) ( figure S4 ) and showed that the increased variation in 1 6 2 post-FMT patients resulted from donor strain transfer instead of temporal variability 1 6 3 or abundance variation beyond detection thresholds. 1 6 4
Furthermore, marked differences in colonization success were observed between UC 1 6 5 or CD recipients who shared a donor (subjects CD-1,2,3,8, and UC-1,2). 3 days after 1 6 6 treatment, UC-1 ,2 retained a higher amount of donor-specific SNVs compared with 1 6 7 CD-1,2,3,8 (48.9%, 44.4%,11.9%, 3.4%,1.5% and 9.3%, respectively). Extensive 1 6 8 coexistence of donor and recipient strains (CD: in 44.1 ± 17.1% of shared species, UC: 1 6 9 21.3 ± 14.1%) were found in all other recipients, which persisted for at least one 1 7 0 months. This suggested that novel strains can colonize in the gut without replacing the 1 7 1 indigenous strain population of the recipient. It appeared that introduced strains were 1 7 2 more likely to establish in a new environment if the species was already present. We 1 7 3 sought to determine the extent of donor and recipient strain coexistence across species 1 7 4 and pattern of donor strains establishing alongside indigenous strains of the recipient 1 7 5 was seen. 1 7 6
While CD FMT species showed more resistance to introduced strains compared with 1 7 7 UC, durability of donor strains varied widely for most species. Donor strains of 1 7 8
Biffidobacterium longum, Citrobacter sp, Bacteroides vulgatus, Dorea longicatena, 1 7 9
Eubacterium hallii appeared to dominate recipient strains. In contrast, recipient strains 1 8 0 like Clostridium scindens, Coprococcus comes, Burkholdenriales bacterium, Alistipes 1 8 1 putredinis showed resistance to donor strains (figure 4). What amazed us was that 1 8 2 EET treatment also presented the potential to change the recipient strains. Bacteroides 1 8 3 sp, Klebsiella pneumonia presented newly SNPs up to 40%, while 1 8 4
Methanobrevibacter smithii showed resistance to EEN treatment (figure 5). 1 8 5
Construction of a prediction model for post-FMT patients' mOTUs 1 8 6
We subsequently performed random forest analysis (RF analysis) to construct a 1 8 7 classification model to predict the presence and absence of species in post-FMT 1 8 8
patients and a regression model to predict the abundance of those species. Recipients' 1 8 9 and the donors' mOTUs along with their clinical metadata before FMT were used as 1 9 0 predictors to construct our model. As for classification, averaged across all predicted 1 9 1 species, we got area under the curve (AUC) = 74.2%, SD = 16%; for regression 1 9 2 model, we got rho = 0.478, P < 2.2e-16 ( figure 6A ). Results indicated that for some 1 9 3 species of post-FMT patient both the existence and abundance were predictable. The RF analysis assigned a variable importance score to each predictor to indicate 2 0 0 their relative contribution to the model. Among the top 40 important variables we 2 0 1 picked (see in methods part) ( figure 6B Streptococcus.anginosus was reported to be associated with colorectal cancer and 2 0 6
Ruminococcus..gnavus was ever found to be associated with a certain kind of 2 0 7 immunological rejection. Summarizing all those important variables, we found that 2 0 8 species composition and clinic metadata of recipients took the prominent place. Thus, 2 0 9
we suggested that in practice, people who fit the common healthy standards could be 2 1 0 recruited as donor while patients may need to be stratified for better treatment effect. Our explanation for the importance of recipient phenotype, to some extent, was that it 2 1 2 could reflect the gut healthy and immune status. To explain the biggest part of 2 1 3 recipient mOTUs, we could assume that the engraftment of new species should have a 2 1 4 competition process with those primitive microbiomes of recipient. 
Relationships between mOTU change with clinical indexes change 2 1 6
Of all 15 patients, 3 days after FMT treatment, 8 out of 11 CD patients were relieved, 2 1 7 3 out of 4 UC patients were relieved (table S1). Clinical improvement was defined as 2 1 1 1 decrease of Harvey-Bradshaw Index > 3 for CD, and decrease of Mayo score > 3 for 2 1 9 UC (table S1). 2 2 0
To evaluate the diagnostic value of FMT, we built relationships between mOTU 2 2 1 change with clinical indexes change by conducting a three-step procedure. Firstly, we 2 2 2 tested whether the clinical indexed change before and after FMT were significantly 2 2 3 higher than 0 using Student's t-test ( figure 7A ). Results showed that Mental status Bacteroides.fragilis. Thirdly, we tended to examine the relationships of FMT-induced 2 3 9 changes in biochemical markers with some disease-associated characteristics such as 2 4 0 also discovered to act as important predictors in our random forest classification 2 4 6 model, we thus inferred that it may be profitable to have FMT at an early stage of IBD 2 4 7 and that the younger the patient, the better the treatment effect based on this selected 2 4 8 population. Fecal microbiota transplantation has been utilized sporadically for over 50 years and it 2 5 1 is best known as a treatment for recurrent Clostridium difficile infection. However, 2 5 2 the mechanism by which it exerts its therapeutic effects have not yet been fully 2 5 3 elucidated. 2 5 4
Our results confirmed that CD patients were characterized with reduced diversity, all 2 5 5 1 3 inflammatory conditions of the colon and small intestine that could be triggered by a 2 6 3 dysbiosis of gut flora and be relieved via an introduction of fecal flora from healthy 2 6 4 people. These findings acted as a basis for future microbiome-based therapeutics and 2 6 5 patient stratification in preclinical and clinical phase of IBD. The identified elements 2 6 6 need to be validated in larger and independent cohorts with better experiments design. Functional analysis of the species and in vitro characterizations of the strains will be 2 6 8 necessary to verify whether a few of the identified markers are "key species" or "key 2 6 9 strains" for the relief of IBD patients after FMT treatment. With further investigation 2 7 0 of the possible mechanisms of FMT, there will be a great promise for the development 2 7 1 of microbiota-based precision treatments. (12) study. Samples were collected at baseline and after 2-week EEN treatment and 2 8 5 standards of recruitment and sequencing strategy were described in that paper. In summary, 34 samples were used in analysis of the allogenic FMT group; 25 for the 2 9 0 autologous; 10 for the healthy group; and 28 for the EEN group. Raw reads were quality controlled by trimming low quality bases and removing 2 9 3 host-related reads using cOMG with default parameters (13). Species level profiling was conducted using m-OTUS.pl to generate the mOTUs 2 9 5 profiles which maps the high quality reads against the m-OTUS.v1.padded database 2 9 6 and outputs metagenomic OUT linkage groups (m-OTUS) generating both taxa 2 9 7 previously identified and those yet to be isolated and characterized, as described by 2 9 8 Sunagawa S et al. (14) . For strain-level profiling, high quality reads were mapped to 2 9 9 over 5,000 bacterial species' representative genomes with default parameters using 3 0 0 metaSNV (15). Statistical analyses were performed in R using the packages vegan, Hmcc, pROC, and 3 0 3 randomForest. All statistical tests used were two-sided. Fecal microbiome derived features and visualization. Firstly, we departed its 3 0 7 composition into 4 parts: donor-and recipient-specific species, newly gained species 3 0 8 and species common to donor and recipient. After quantification of those 4 parts of 3 0 9 patients, we averaged those across CD and UC patients separately. Microbiota 3 1 0 variation between individuals was visualized using Bray-Curtis dissimilarity on the 3 1 1 mOTUs -abundance matrix. And distance between the donor and the recipient after 3 1 2 the transplantation and before and after the transplantation was compared. Firstly, we picked a mtry parameter with the lowest error using rfcv function with 3 1 7 5-folded cross validation. Then we use the randomForest function to do classification 3 1 8 across all mOTUs. In total, we got 123 randomForest models and we computed auc 3 1 9 for each. We chose important variables only from those models which had a good 3 2 0 performance in prediction that means auc was bigger than 0.9. We extracted top 40 3 2 1 variables by ranking both their frequency and their contributions across those well 3 2 2 performed classification models. adjust p value. After that, we pick those pairs with q-value smaller than 0.05 to draw a We gratefully acknowledge colleagues at the Second Affiliated Hospital of Nanjing 3 3 4
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